IR-Med, Inc. Quarterly Operating Income (Loss) in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IR-Med, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2024.
  • IR-Med, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$601K, a 49.8% increase year-over-year.
  • IR-Med, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$2.88M, a 49.6% increase year-over-year.
  • IR-Med, Inc. annual Operating Income (Loss) for 2023 was -$4.91M, a 3.13% decline from 2022.
  • IR-Med, Inc. annual Operating Income (Loss) for 2022 was -$4.76M, a 29.6% decline from 2021.
  • IR-Med, Inc. annual Operating Income (Loss) for 2021 was -$3.68M, a 403% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.88M -$601K +$596K +49.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$3.48M -$358K +$742K +67.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$4.22M -$658K +$694K +51.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$4.91M -$1.26M +$800K +38.8% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-04-08
Q3 2023 -$5.71M -$1.2M -$321K -36.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$5.39M -$1.1M -$129K -13.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$5.26M -$1.35M -$499K -58.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$4.76M -$2.06M -$1.06M -105% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-04-08
Q3 2022 -$3.71M -$876K -$154K -21.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.55M -$971K +$545K +36% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$4.1M -$853K -$422K -97.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$3.68M -$1.01M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-05-11
Q3 2021 -$722K -$642K -803% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.52M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$431K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 -$80K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.